Literature DB >> 32549838

Time to Change Standard of Care to Include Screening for Common Disease-Inducing Toxicants.

Joseph Pizzorno.   

Abstract

Foundational to the standard of care is diagnosis of overt disease as well as testing for early predictors of future disease. Obvious examples of the later include measurement of blood pressure and cholesterol. The time has come to add to this thinking early detection of the environmental causes of disease. Substantial research now shows that metal and chemical contamination of the environment has resulted in body loads of these toxicants at high enough levels to induce disease. The time has come to add screening for toxicant load to the standard of care.
Copyright © 2019 InnoVision Professional Media Inc.

Entities:  

Year:  2019        PMID: 32549838      PMCID: PMC7219443     

Source DB:  PubMed          Journal:  Integr Med (Encinitas)        ISSN: 1546-993X


  10 in total

1.  Arsenic exposure and cancer mortality in a US-based prospective cohort: the strong heart study.

Authors:  Esther García-Esquinas; Marina Pollán; Jason G Umans; Kevin A Francesconi; Walter Goessler; Eliseo Guallar; Barbara Howard; John Farley; Lyle G Best; Ana Navas-Acien
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-10-17       Impact factor: 4.254

2.  Gamma-glutamyltransferase and diabetes--a 4 year follow-up study.

Authors:  D-H Lee; M-H Ha; J-H Kim; D C Christiani; M D Gross; M Steffes; R Blomhoff; D R Jacobs
Journal:  Diabetologia       Date:  2003-03-01       Impact factor: 10.122

3.  Distribution, determinants, and prognostic value of gamma-glutamyltransferase for all-cause mortality in a cohort of construction workers from southern Germany.

Authors:  H Brenner; D Rothenbacher; V Arndt; S Schuberth; E Fraisse; T M Fliedner
Journal:  Prev Med       Date:  1997 May-Jun       Impact factor: 4.018

4.  Low-level lead exposure and mortality in US adults: a population-based cohort study.

Authors:  Bruce P Lanphear; Stephen Rauch; Peggy Auinger; Ryan W Allen; Richard W Hornung
Journal:  Lancet Public Health       Date:  2018-03-12

5.  Is serum gamma-glutamyltransferase an exposure marker of xenobiotics? Empirical evidence with polycylic aromatic hydrocarbon.

Authors:  Duk-Hee Lee; David R Jacobs
Journal:  Clin Chem Lab Med       Date:  2009       Impact factor: 3.694

6.  Menopause and lead body burden among US women aged 45-55, NHANES 1999-2010.

Authors:  Pauline Mendola; Kate Brett; Jessica N Dibari; Anna Z Pollack; Rashmi Tandon; Edmond D Shenassa
Journal:  Environ Res       Date:  2013-01-24       Impact factor: 6.498

7.  Correlates of bone and blood lead levels among middle-aged and elderly women.

Authors:  Susan A Korrick; Joel Schwartz; Shirng-Wern Tsaih; David J Hunter; Antonio Aro; Bernard Rosner; Frank E Speizer; Howard Hu
Journal:  Am J Epidemiol       Date:  2002-08-15       Impact factor: 4.897

Review 8.  Childhood Lead Exposure and Adult Neurodegenerative Disease.

Authors:  Aaron Reuben
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

9.  Declining exposures to lead and cadmium contribute to explaining the reduction of cardiovascular mortality in the US population, 1988-2004.

Authors:  Adrian Ruiz-Hernandez; Ana Navas-Acien; Roberto Pastor-Barriuso; Ciprian M Crainiceanu; Josep Redon; Eliseo Guallar; Maria Tellez-Plaza
Journal:  Int J Epidemiol       Date:  2017-12-01       Impact factor: 7.196

10.  Cumulative lead exposure and age at menopause in the Nurses' Health Study cohort.

Authors:  Ki-Do Eum; Marc G Weisskopf; Linda H Nie; Howard Hu; Susan A Korrick
Journal:  Environ Health Perspect       Date:  2014-01-07       Impact factor: 9.031

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.